Cargando…
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe
ERCC1/XPF is a heterodimeric DNA endonuclease critical for repair of certain chemotherapeutic agents. We recently identified that ERCC1- and p53-deficient lung cancer cells are tolerant to platinum-based chemotherapy. ATR inhibition synergistically re-stored platinum sensitivity to platinum tolerant...
Autores principales: | Heyza, Joshua R, Ekinci, Elmira, Lindquist, Jacob, Lei, Wen, Yunker, Christopher, Vinothkumar, Vilvanathan, Rowbotham, Rachelle, Polin, Lisa, Snider, Natalie G, Van Buren, Eric, Watza, Donovan, Back, Jessica B, Chen, Wei, Mamdani, Hirva, Schwartz, Ann G, Turchi, John J, Bepler, Gerold, Patrick, Steve M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832712/ https://www.ncbi.nlm.nih.gov/pubmed/36644397 http://dx.doi.org/10.1093/narcan/zcac045 |
Ejemplares similares
-
Intrinsic ATR signaling shapes DNA end resection and suppresses toxic DNA-PKcs signaling
por: Dibitetto, Diego, et al.
Publicado: (2020) -
APOBEC3 enzymes mediate efficacy of cisplatin and are epistatic with base excision repair and mismatch repair in platinum response
por: Conner, Kayla L, et al.
Publicado: (2020) -
SMARCA4 deficiency-associated heterochromatin induces intrinsic DNA replication stress and susceptibility to ATR inhibition in lung adenocarcinoma
por: Kurashima, Kiminori, et al.
Publicado: (2020) -
Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors
por: Golder, Anya, et al.
Publicado: (2022) -
Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks
por: Mendoza-Munoz, Pamela L, et al.
Publicado: (2023)